REVLIMID now available in UK for adult patients with previously untreated multiple myeloma who are not eligible for transplant Celgene Limited, a wholly owned subsidiary of Celgene Corporation, has announced that REVLIMID is now available for adult patients with previously untreated multiple myeloma who are not eligible for stem cell transplant.
http://ift.tt/1btY2lR
No comments:
Post a Comment